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Results 
The percentage difference between measurements and 
calculations in the centre (at isocentre) of the Delta4 
phantom is shown in fig 2 for 10 x 10 cm² field 
configurations both for 6 MV and 15 MV. Graphs for the 
other investigated field sizes are similar. The percentage 
differences for the CT-based and simple model are 
fluctuating around zero, whereas the percentage 
differences without table and with the advanced table 
model are all either negative or positive and have a larger 
range. This means that the CT-based and simple table 
model are equivalent to each other and superior to the 
others. Gamma analysis of the prostate plans shows little 
variances between the different models. This can be 
declared by the observation in fig 2 that the differences 
between measurements and calculations are below 1% for 
full arcs.  
 
 
 
Conclusion 
The quality of the simple model and the CT-based model 
are equivalent. It is surprising that the quality of the 
advanced model is not satisfying. We prefer to use the 
simple model in routine clinical practice since it is more 
user-friendly than the CT-based model. 
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Purpose or Objective 
High density implants cause artefacts in CT and MRI which 
is problematic for the delineation process and dose 
calculation. The high density titanium implants are not 
properly accounted for in the dose calculation algorithms 
of the treatment planning system (TPS). This can result in 
an incorrect computation of the dose on TPS. Implants 
made from carbon fiber reinforced polyetheretherketone 
(CFR-PEEK) are radiolucent, non-magnetic and have a low 
density.  Therefore, they do not produce artefacts and 
should be more compatible with the TPS algorithms. This 
study aims to assess the advantages of CFR PEEK vs. 
titanium implants in both photon and pencil beam 
scanning proton therapy (PT) for spinal treatment. 
Material and Methods 
A unique phantom was developed with 4 interchangeable 
inserts at spine level Th 7-11: one reference case with a 
native spine and three with a spinal stabilization implant 
consisting of: titanium, CFR-PEEK and a hybrid 
composition of both materials. These 4 scenarios were 
irradiated with both proton and photon plans with a 
fraction dose of 2 Gy. A single field and a clinical scenario 
with 3 fields Intensity Modulated PT (IMPT) plan with 
spinal cord sparing were applied with protons. Static field 
plans and VMAT plans were created with the Varian Eclipse 
planning system and applied with a Varian linac with 6 MV 
photons. The severity of the artefacts was measured by 
size, contouring time and overlap with other structures. 
The delivered dose was measured with GafChromic films. 
 
 
 
Results 
The total volume of artefacts on CT was 390.6 cc, 174.2 
cc and 33.9 cc for the titanium, hybrid and CFR-PEEK case 
respectively; with 7.5% of the spinal cord and 58.2% of the 
GTV affected by artefacts for the titanium while these 
structures were not affected in the CFR-PEEK cases. This 
resulted in a delineation time 4 times shorter for CFR-PEEK 
case (43.7 ± 36.5 min) compared to the titanium case 
(172.0 ± 111.6 min). The single field proton plans showed 
a large deviation of measured dose in the titanium 
containing cases. In the clinical plans this improved 
slightly, but cold spots still exceeded clinical acceptance 
levels of >5%. Photon plans showed the same effect for a 
single dorsal static field. The disturbance by titanium 
results in hot and cold spots with dose deviations up to 
25% of the prescribed dose. The applied VMAT plans 
showed no detectable dose deviations compared to the 
reference case. The CFR-PEEK showed in all plans a result 
comparable to reference. The maximum deviation 
measured by GafChromic films with respect to the 
prescribed dose for all cases an both planning techniques 
are presented in Table I. 
 
 
 
Conclusion 
Whereas titanium leads to severe artefacts, prolonged 
planning time and incorrect dose calculations, use of CFR-
PEEK implants solved all these issues. As such, CFR-PEEK 
implants should be used during the surgical procedure if 
adjuvant PT is considered for a patient. 
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respectively; with 7.5% of the spinal cord and 58.2% of the 
GTV affected by artefacts for the titanium while these 
structures were not affected in the CFR-PEEK cases. This 
resulted in a delineation time 4 times shorter for CFR-PEEK 
case (43.7 ± 36.5 min) compared to the titanium case 
(172.0 ± 111.6 min). The single field proton plans showed 
a large deviation of measured dose in the titanium 
containing cases. In the clinical plans this improved 
slightly, but cold spots still exceeded clinical acceptance 
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single dorsal static field. The disturbance by titanium 
results in hot and cold spots with dose deviations up to 
25% of the prescribed dose. The applied VMAT plans 
showed no detectable dose deviations compared to the 
reference case. The CFR-PEEK showed in all plans a result 
comparable to reference. The maximum deviation 
measured by GafChromic films with respect to the 
prescribed dose for all cases an both planning techniques 
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Purpose or Objective 
In a previous work, presence of gold markers, contrast in 
the bladder and rectum interpretation were identified as 
potential factors influencing tissue segmentation and 
causing discrepancies between dose distributions from the 
TPS and a Monte Carlo (MC) system [Phys Med 51 (2018) 
32]. Thus, the objective of this work is to quantify 
dosimetric effects on the target dose determination due 
to uncertainties in tissue segmentation for prostate cancer 
treatments. 
Material and Methods 
CT scans of more than 200 consecutive VMAT plans for 
prostate cancer were reviewed. Three groups of plans 
were selected: (i) 18 plans with enhanced CT artifacts in 
the PTV due to presence of gold markers but no contrast 
in the bladder or visible air in the rectum as a part of the 
PTV; (ii) 15 plans with contrast in the bladder as a part of 
the PTV but no marker artifacts or air in the rectum in the 
PTV; (iii) 15 plans with air in the rectum as a part of the 
PTV but no contrast in the bladder in the PTV. Calculations 
were carried out by Eclipse™ TPS algorithms, AAA and 
Acuros XB (dose to medium (AXBm)) and by an MC system 
(dose to water/medium (MCw)/(MCm)) based on the 
EGSnrc. Dose distributions were obtained on the original 
CT scans as well as on the modified scans by setting HU to 
zero in the PTV, the bladder and the rectum for groups (i), 
(ii) and (iii), correspondingly. DVH estimates such as the 
mean dose to the CTV, PTV, D98% PTV and D2%PTV were 
compared to evaluate the effect of the various factors. 
Results 
The parameter D98%PTV was most sensitive to uncertainties 
in tissue segmentation, notably gold markers and air in the 
rectum. The maximum difference between AAA and MCw 
was 2.8% (i) and 5.4% (ii) and between AXBm and MCm 1.1% 
(i) and 4.5% (ii) (Figure 1). The variations were reduced to 
± 2.1% when D98%PTV was determined on modified scans 
with HU=0 in the PTV or the rectum. A more detailed 
investigation showed that the TPS dose domination may be 
distributed in larger parts of the PTV volume with markers 
and visible CT artefacts (Figure 2). For group (ii), AAA may 
dominate locally, in the air part of the PTV, whereas the 
dose to the rest of the PTV may be lower compared to 
MCw. In the case of contrast in the bladder, all DVH 
parameters showed similar results for calculations on 
original and modified CT scans. The median difference 
between AAA, AXBm, MCw and MCm estimations of the mean 
dose to the CTV and the PTV was within 0.5% for all cases. 
Mean dose deviations up to 2.4% were observed for 
individual plans.  
 
 
 
Figure 1. The median difference between DVH parameters 
estimated by AXBm and MCm for the three groups. Green 
bars – original scans, yellow bars – modified scans. Error 
bars; min-max variation of the difference.  
 
 
 
Figure 2. Dose distributions for selected plans from (i) and 
(ii). Color scale starts with 98%. 
 
Conclusion 
The presence of gold markers and inclusion of rectum air 
in the PTV may increase the variations in the D98%PTV 
estimation. However, no clinically relevant dosimetric 
effects were detected. 
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Purpose or Objective 
To verify the dose delivered by a single isocenter 
volumetric modulated arc therapy (VMAT) for stereotactic 
radiosurgery (SRS) of multiple brain metastases. 
Material and Methods 
Verification measurements were performed on single 
isocenter SRS plans of patients with 4-10 brain metastases 
treated on a Varian TrueBeamSTx. The 3x8Gy plans, 
calculated with Varian Eclipse treatment planning system 
(TPS) (Acuros version 15.5.11, 1mm grid size), consisted 
of 2 coplanar arcs and were normalized to deliver 100 % of 
the prescription dose to all lesions.  
Firstly, the dosimetric agreement between radiochromic 
EBT-XD film and the calculation by the TPS was 
investigated. Films were placed in an Alderson radiation 
therapy head phantom (ART-200) in 2 transverse planes 
both intersecting high dose regions. The phantom was 
positioned using a CBCT and 6 degrees of freedom (6D) 
couch. The film dosimetry measurement was analysed by 
Film QA pro software (Ashland) using the one-scan method 
with a dose threshold of 50% and a local gamma criterion 
of 2%, 2mm[1].  
Secondly, to check the consistency of the film 
measurement, portal dose measurements were done by 
acquiring MV pre-treatment greyscale value images per 
field using a Varian aS1000 flat panel and converting them 
to full-scatter portal dose images using the dosimetric 
calibration model described in [2]. These measured portal 
dose images were converted to fluence and reconstructed 
to a 3D dose distribution in the CT data set. The evaluation 
was performed using a gamma criterion of 3%, 3mm.  
Results 
Comparison between film and calculation show a mean 
agreement of 96.3% for both measurement planes for all 
plans with 4-10 brain lesions. The gamma analysis of the 
reconstructed 3D dose distribution resulting from the 
portal dose measurements shows a mean agreement score 
of 99.7%. 
Conclusion 
We have found that both film as well as portal dose based 
dosimetry show comparable agreements with TPS 
